Free YouTube Transcribe

Video transcript

In Conversation with Lance Little and Harjit Gill

Roche · 1,738 words · 8 min read

Want to search this transcript, jump the video from any line, or download it as TXT, SRT, or VTT?

Open in the transcript tool

Full transcript

0:00Well Harjit, it’s been an absolute pleasure...

0:04It has been!

0:04Lance, it’s been a pleasure being here!

0:07I love this In Conversation series that you are doing.

0:09Fantastic!

0:23Hey guys,

0:24welcome to another In Conversation for this year.

0:26In the spirit of becoming a better version of ourselves

0:30and continuous learning.

0:31It's my absolute pleasure to have with me,

0:34Harjit Gill, who is the CEO of APACMed

0:36APACMed for those of you that are not sure

0:38is the industry body for across Asia Pacific on all

0:42med tech including IVD as well.

0:44And so our topic today and the reason

0:46why we've got Harjit here with us is to talk about

0:48and explore the concepts around healthcare and equity

0:51and focusing on the areas of women's health.

0:54It's great to be here, Lance,

0:55especially on a topic

0:56that’s so close to my heart,

0:58and that's women's health.

0:59No matter how far we've come in many different areas,

1:03I still think inequity

1:05when it comes to women's health,

1:07we've still got a long way to go.

1:09There's a lot of work to do and I think

1:10as part of the discussion today,

1:12I think one of the things I'd like to explore is

1:14people talk about access,

1:15that there's a nuance to access,

1:16which is around inequity.

1:18I think that's a conversation

1:19we need to have more and more.

1:22Healthcare inequity for women, for me,

1:24really is about outcomes.

1:26Outcomes that are far behind the ones that you see

1:29for their male counterparts.

1:31I think there's still a long way to go

1:32when we talk about

1:34improving healthcare access for women

1:38and getting more parity when it comes to outcomes.

1:41A lot of the reasons though, behind this,

1:43especially in this region,

1:45have to do with financial security

1:47and autonomy for women.

1:48I mean, we are half the world's population, but still

1:51biggest part of the poor population are women.

1:54Secondly, there are many societal

1:56and cultural barriers in this region,

1:58and that just puts a lot of restrictions,

2:00especially for women, in terms of having a certain degree of autonomy

2:04in managing their own health.

2:06Women's access to education

2:08still needs to go a long way in terms of

2:11improving their understanding,

2:14but also taking ownership for their health.

2:17Societal pressures,

2:18I think, in this region are also putting

2:21a lot of pressure on women

2:22because they don't seem

2:24in all cases to have that autonomy.

2:26And I think there's a statistic that I read,

2:28in fact, from the work that Roche did,

2:31that one in five women actually delay getting treatment

2:34for specific healthcare issues

2:36because they're busy with the family.

2:38For me,

2:39one of the questions I get asked is

2:41this seems to be lumped in as a general access question

2:44and in all honesty, it's not.

2:46So even if you said

2:48we have 47% of the world's population does not get access

2:52to basic diagnostics.

2:53Okay.

2:54If you solve that problem,

2:55we still have an equities,

2:57given that the system doesn't deliver

2:59what specific groups need,

3:01men versus women as you've described.

3:04For me, I think almost the role of a woman

3:07in the household according to society,

3:09women will put their families well-being ahead of their own

3:14and maybe not interact with healthcare systems as much.

3:17So I think, there's so many elements

3:20that play into this question around inequity

3:22and we've got to move beyond the access conversation

3:25as a bucket and get into specifics of what needs to be done

3:30to address these challenges.

3:32I really think that

3:33one of the ways to get around that is to educate more.

3:36And whatever solutions

3:37that we put out there as an industry,

3:40they should go hand in hand with education.

3:43And I think one of the ways

3:44actually through my experience

3:46is really about building communities,

3:49because women tend to rely so much on each other.

3:53And it's only through putting communities,

3:56grassroot communities,

3:58that you can actually get certain messages across.

4:03The last thing I would say actually is also industry

4:05has quite a big role in terms of shaping,

4:08how this can be improved.

4:11You pick up on the industry piece

4:12and this is something we talk about a lot internally

4:15and as a market leader as we are in IVD,

4:18we've delivered a lot of tools

4:21into the healthcare system.

4:22And one of the things that we need to understand is

4:25even if those tools are available in an environment,

4:28they're not necessarily being utilised

4:30for the reasons that you described.

4:33And then so what's our role as an organisation

4:36to help go the next step.

4:38And what we need to start doing,

4:40as I described as a little bit

4:42like a football game, for example,

4:44instead of being on the sidelines

4:46and providing balls, boots and socks,

4:49we need to get into the game

4:51and start addressing the ancillary reasons why a test,

4:57a critical test, particularly, is not being taken out.

5:01For example, we know the societal dynamics

5:04and in a sense of judgment actually influences many people.

5:09And we've seen this in terms of the uptake of

5:11HPV testing for cervical cancer in women

5:14in places like Malaysia.

5:16What do you think industries could do differently

5:19when they then take their solutions to market?

5:23And I've seen some great examples in the region,

5:27especially around maternal deaths.

5:31So if you see today,

5:32we're still losing 300,000 women

5:35during pregnancy and childbirth.

5:37And 99% of those women are in this region

5:41and 75% of that can be improved through education alone.

5:44So having a education element

5:48as part of the solutions that you offer,

5:51I feel is one way.

5:52I could probably speak for all of us

5:53in the industry where we would say yes,

5:56but we have education.

5:57But I think what is the piece

5:59that's missing that we need to crack is,

6:03we need to get alongside everywhere,

6:05everyone in that healthcare journey,

6:08shoulder to shoulder and say,

6:09this is what we're trying to solve for.

6:11Regardless of whether you're a healthcare provider

6:13or whether you're from the industry

6:15or government,

6:17it is going to take all of us to deliver our piece

6:21to solve that problem.

6:22And I think this is the step

6:24that hasn't gone far enough.

6:26I mean, companies, ourselves included,

6:28it's more about how do you deploy your educational content

6:33and when you address that, you then start thinking about,

6:35what is it?

6:36We're a science based company,

6:39so we're very comfortable

6:40having conversations around sensitivity and specificity.

6:44But does that land with a woman in Malaysia

6:47when we're talking about HPV testing?

6:49No, of course not.

6:50So, it's really taking another step

6:53into the healthcare game

6:54that I think we all need to do.

6:55But I think that's what's so interesting

6:56about our industry right now,

6:59because if you're working in this industry,

7:01it is about working and pulling together that ecosystem

7:05to get those solutions out.

7:07Just taking the solutions alone

7:09or having the solutions alone is not going to cut it.

7:12So I think as companies get more and more understanding

7:17around specific disease areas

7:19and especially the cultural taboos around them,

7:24we will require a different approach.

7:26And finding a way to address those.

7:28Exactly.

7:28Because we won't be able to reach the levels

7:32we want to in terms of,

7:34healthcare outcomes if we don't do that.

7:37So I think we need to acknowledge

7:38that this is a big complex topic, right?

7:40So what I'd like to see is some

7:43and to use today's terminology,

7:44some successful use cases

7:46where we're actually addressing

7:49the various elements of inequity

7:51for perhaps a disease state.

7:53So if we were to take

7:54something like cervical cancer for example,

7:57I would love to see a successful blueprint

8:00put together in an environment

8:02that has the challenges of society,

8:05finance and the lack of education.

8:07And the villages come together.

8:09And we've actually created a model

8:11that we know works,

8:13that we can then go, okay, let's now scale this.

8:17And I think that will help us break

8:20the mold of healthcare delivery today.

8:23And I would just love us to see that

8:26because then we're dealing with the systematic problems,

8:29not the individual symptoms.

8:31And that I'd love to see us be able to achieve that.

8:34And I think you're totally right, Lance.

8:35This is a systemic issue

8:38that needs to be tackled from all fronts.

8:41And if I look at the work that we do at APACMed,

8:44it is really around building advocacy

8:47on key issues like this.

8:48So I think as more and more solutions are developed,

8:52having those use cases that we could use

8:55to share with policymakers

8:57and to get the relevant reimbursement

9:00or regulatory approvals in the country is critical.

9:04So that's a way that we can actually collaborate

9:07and that's the way APACMed leverage is then

9:09the work that our member companies do.

9:12Yeah, totally agree.

9:13And if you look at it from the policymakers perspective as well,

9:16I mean, everybody knows

9:17there are these problems and challenges,

9:19but it takes a brave individual or group

9:22to bring in a new model.

9:24So if we're able to show use cases

9:27with proof points that show

9:28actually this step is the right thing to do,

9:31minimise the risk,

9:31address whatever elements need to be addressed,

9:34then the willingness for policymakers

9:36to take those things up should be a lot more.

9:39And this is a big gap in terms of capacity

9:42and capability in this region

9:43when we talk about policymakers and regulators.

9:46So those people in that position

9:48to make the change.

9:49And I think we have a great opportunity

9:52also to build those capabilities

9:55by sharing some of these new solutions.

9:58Well, Hajit, thank you so much.

9:59It's been an absolute pleasure having you here

10:02in our discussion today.

10:03In Conversation is a program that we have

10:06within Roche Diagnostics Asia Pacific,

10:08whereby we discuss key topics in healthcare

10:11and try and bring out

10:13some of the more core elements associated with those topics.

10:16So as we can educate the environment,

10:18the people in healthcare

10:19and the people around to improve the lives

10:22of people across Asia Pacific.

10:24So once again, thank you so much.

10:26Thanks for your insights.

10:27I wish you all the best.

10:28It was a pleasure.

10:29Thank you for having me.

10:30Thank you.

More from Roche

Recently added transcripts

Browse the whole transcript library

This transcript was generated from the captions YouTube publishes for this video. Get the transcript of any YouTube video atfreeyoutubetranscribe.com, free, unlimited, no sign-up.